BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28094212)

  • 21. Toxicity and outcome of intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy for oropharyngeal cancer: a matched-pair analysis.
    Al-Mamgani A; Van Rooij P; Tans L; Teguh DN; Levendag PC
    Technol Cancer Res Treat; 2013 Apr; 12(2):123-30. PubMed ID: 23098281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cervical nodal level V can safely be omitted in the treatment of locally advanced oropharyngeal squamous cell carcinoma with definitive IMRT.
    Gutiontov S; Leeman J; Lok B; Romesser P; Riaz N; Tsai CJ; Lee N; McBride S
    Oral Oncol; 2016 Jul; 58():27-31. PubMed ID: 27311399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long term results of postoperative Intensity-Modulated Radiation Therapy (IMRT) in the treatment of Squamous Cell Carcinoma (SCC) located in the oropharynx or oral cavity.
    Hoffmann M; Saleh-Ebrahimi L; Zwicker F; Haering P; Schwahofer A; Debus J; Huber PE; Roeder F
    Radiat Oncol; 2015 Dec; 10():251. PubMed ID: 26637471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Level IB nodal involvement in oropharyngeal carcinoma: implications for submandibular gland-sparing intensity-modulated radiotherapy.
    Yu Y; Daly ME; Farwell DG; Luu Q; Gandour-Edwards R; Donald PJ; Chen AM
    Laryngoscope; 2015 Mar; 125(3):608-14. PubMed ID: 25215891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer.
    Bussels B; Maes A; Hermans R; Nuyts S; Weltens C; Van den Bogaert W
    Radiother Oncol; 2004 Aug; 72(2):119-27. PubMed ID: 15297131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elective Nodal Irradiation and Patterns of Failure in Head and Neck Cancer After Primary Radiation Therapy.
    Kjems J; Gothelf AB; Håkansson K; Specht L; Kristensen CA; Friborg J
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):775-82. PubMed ID: 26972650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of contralateral submandibular gland sparing in locally advanced oropharyngeal cancers: A multicenter review.
    Robin TP; Gan GN; Tam M; Westerly D; Riaz N; Karam SD; Lee N; Raben D
    Head Neck; 2016 Apr; 38(4):506-11. PubMed ID: 25482748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II study of de-intensified intensity-modulated radiotherapy and concurrent carboplatin/5-fluorouracil in lateralized p16-associated oropharyngeal carcinoma.
    Bahig H; Lambert L; Filion E; Soulières D; Guertin L; Ayad T; Christopoulos A; Bissada E; Alizadeh M; Bélair M; Nguyen-Tan PF
    Head Neck; 2020 Dec; 42(12):3479-3489. PubMed ID: 32866313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer.
    Chen AM; Farwell DG; Luu Q; Chen LM; Vijayakumar S; Purdy JA
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1423-9. PubMed ID: 20656416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Constraints of the dentist are consistent with the results of an optimal irradiation with modulated intensity in N0 oropharyngeal cancer].
    Jaussaud S; Guihard S; Niederst C; Borel C; Meyer P; Hémar P; Schultz P; Noël G; Féki A
    Cancer Radiother; 2013; 17(4):265-71. PubMed ID: 23726044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymph node metastasis in sinonasal squamous cell carcinoma treated with IMRT/3D-CRT.
    Guan X; Wang X; Liu Y; Hu C; Zhu G
    Oral Oncol; 2013 Jan; 49(1):60-5. PubMed ID: 22884302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: sites of locoregional relapse and survival.
    Collan J; Kapanen M; Mäkitie A; Nyman H; Joensuu H; Tenhunen M; Saarilahti K
    Acta Oncol; 2012 Jul; 51(6):735-42. PubMed ID: 22150115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional recurrence of oropharyngeal cancer after definitive radiotherapy: a case control study.
    Söderström K; Nilsson P; Dalianis T; Kjellén E; Zackrisson B
    Radiat Oncol; 2015 May; 10():117. PubMed ID: 26014350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
    McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
    Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: clinical outcomes and patterns of failure.
    Daly ME; Le QT; Maxim PG; Loo BW; Kaplan MJ; Fischbein NJ; Pinto H; Chang DT
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1339-46. PubMed ID: 19540068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Level II lymph nodes and radiation-induced xerostomia.
    Astreinidou E; Dehnad H; Terhaard CH; Raaijmakers CP
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):124-31. PubMed ID: 14697429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two-step Intensity-modulated Radiation Therapy for Oropharyngeal Cancer: Initial Clinical Experience and Validation of Clinical Staging.
    Tatebe H; Doi H; Ishikawa K; Kawakami H; Yokokawa M; Nakamatsu K; Kanamori S; Shibata T; Kitano M; Nishimura Y
    Anticancer Res; 2018 Feb; 38(2):979-986. PubMed ID: 29374730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Individualized IMRT treatment approach for cervical lymph node metastases of unknown primary.
    Janssen S; Glanzmann C; Huber G; Studer G
    Strahlenther Onkol; 2014 Apr; 190(4):386-93. PubMed ID: 24638240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is uniform target dose possible in IMRT plans in the head and neck?
    Vineberg KA; Eisbruch A; Coselmon MM; McShan DL; Kessler ML; Fraass BA
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1159-72. PubMed ID: 11955726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation.
    Lee N; Xia P; Fischbein NJ; Akazawa P; Akazawa C; Quivey JM
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):49-60. PubMed ID: 12909215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.